Gemtuzumab ozogamicin: Time to resurrect?

Farhad Ravandi; Elihu H. Estey; Frederick R. Appelbaum; Francesco Lo-Coco; Charles A. Schiffer; Richard A. Larson; Alan K. Burnett; Hagop M. Kantarjian

doi:10.1200/JCO.2012.43.0132

Gemtuzumab ozogamicin: Time to resurrect?

Farhad Ravandi, Elihu H. Estey, Frederick R. Appelbaum, Francesco Lo-Coco, Charles A. Schiffer, Richard A. Larson, Alan K. Burnett, Hagop M. Kantarjian

Leukemia

Research output: Contribution to journal › Comment/debate › peer-review

93 Scopus citations

Original language	English (US)
Pages (from-to)	3921-3923
Number of pages	3
Journal	Journal of Clinical Oncology
Volume	30
Issue number	32
DOIs	https://doi.org/10.1200/JCO.2012.43.0132
State	Published - Nov 10 2012

ASJC Scopus subject areas

Oncology
Cancer Research

Access to Document

10.1200/JCO.2012.43.0132

Cite this

@article{2aaf641533664be6a5b752dbc23d4273,

title = "Gemtuzumab ozogamicin: Time to resurrect?",

author = "Farhad Ravandi and Estey, {Elihu H.} and Appelbaum, {Frederick R.} and Francesco Lo-Coco and Schiffer, {Charles A.} and Larson, {Richard A.} and Burnett, {Alan K.} and Kantarjian, {Hagop M.}",

year = "2012",

month = nov,

day = "10",

doi = "10.1200/JCO.2012.43.0132",

language = "English (US)",

volume = "30",

pages = "3921--3923",

journal = "Journal of Clinical Oncology",

issn = "0732-183X",

publisher = "American Society of Clinical Oncology",

number = "32",

}

TY - JOUR

T1 - Gemtuzumab ozogamicin

T2 - Time to resurrect?

AU - Ravandi, Farhad

AU - Estey, Elihu H.

AU - Appelbaum, Frederick R.

AU - Lo-Coco, Francesco

AU - Schiffer, Charles A.

AU - Larson, Richard A.

AU - Burnett, Alan K.

AU - Kantarjian, Hagop M.

PY - 2012/11/10

Y1 - 2012/11/10

UR - http://www.scopus.com/inward/record.url?scp=84869434807&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84869434807&partnerID=8YFLogxK

U2 - 10.1200/JCO.2012.43.0132

DO - 10.1200/JCO.2012.43.0132

M3 - Comment/debate

C2 - 22987091

AN - SCOPUS:84869434807

SN - 0732-183X

VL - 30

SP - 3921

EP - 3923

JO - Journal of Clinical Oncology

JF - Journal of Clinical Oncology

IS - 32

ER -

Gemtuzumab ozogamicin: Time to resurrect?

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this